RankAlpha logo
Back to Rankings

ATAI

AtaiBeckleyF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
ATAI vs peer average
15/100
ATAI vs. peer average (F vs. B)
Grade spread
A 5 · B 2 · D 1 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

QURE is the first available peer comparator.

uniQure remains a closer small-cap clinical-stage biotech risk template than large-cap pharma; both trade heavily on milestone timing, binary data, and balance-sheet runway rather than current product revenue.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerQUREuniQure
ATAI
AtaiBeckley
QURE
uniQure
Grade
F
F
Momentum
89
90
Value
41
41
Sentiment
28
21
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs QURE

ATAI / QURE
Grade Position
Below peers
ATAI vs. peer average (F vs. B)
15/100
Momentum
89
QURE
Value
41
ATAI
Sentiment
28
ATAI

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ATAI
1
QURE
QURE
F
20/100
Even
2
EYPT
EYPT
A
100/100
-4
3
RGC
Regencell Bioscience Holdings Ltd Common
D
40/100
-1
4
TRVI
Trevi Therapeutics Inc Common
F
20/100
Even
5
SLS
SELLAS Life Sciences Group Inc Common
B
80/100
-3
QURE is the first peer returned for this comparison set.